KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) Revenue (2016 - 2026)

Zimmer Biomet Holdings has reported Revenue over the past 18 years, most recently at $2.1 billion for Q1 2026.

  • For Q1 2026, Revenue rose 9.3% year-over-year to $2.1 billion; the TTM value through Mar 2026 reached $8.4 billion, up 9.23%, while the annual FY2025 figure was $8.2 billion, 7.2% up from the prior year.
  • Revenue for Q1 2026 was $2.1 billion at Zimmer Biomet Holdings, down from $2.2 billion in the prior quarter.
  • Over five years, Revenue peaked at $2.2 billion in Q4 2025 and troughed at $1.7 billion in Q1 2022.
  • A 5-year average of $1.9 billion and a median of $1.9 billion in 2024 define the central range for Revenue.
  • Biggest five-year swings in Revenue: dropped 0.93% in 2022 and later grew 10.9% in 2025.
  • Year by year, Revenue stood at $1.8 billion in 2022, then increased by 6.3% to $1.9 billion in 2023, then increased by 4.28% to $2.0 billion in 2024, then increased by 10.9% to $2.2 billion in 2025, then fell by 7.0% to $2.1 billion in 2026.
  • Business Quant data shows Revenue for ZBH at $2.1 billion in Q1 2026, $2.2 billion in Q4 2025, and $2.0 billion in Q3 2025.